Sol Co., Ltd., winner of the ‘CES 2023 Innovation Award’, will establish an artificial intelligence (AI) research center in Gwangju to foster local talent and create jobs. Gwangju Metropolitan City (Mayor Kang Ki-jeong) signed a business agreement with Sol Co., Ltd., an innovation award winner in the mobile device and accessory category at ‘CES 2023’, and decided to join forces in revitalizing the healthcare industry ecosystem using artificial intelligence.
The CES Innovation Award is an award given by the Consumer Technology Association (CTA), which hosts the expo, to innovative technologies and products that will lead the world. Founded in 2013, Sol Co., Ltd. is a venture company with semiconductor biosensor technology that measures cell numbers quickly and accurately, and developed the world’s first ‘Sol Count Automatic Cell Counter’.
The ‘SolCount Automatic Cell Counter’ is a technology that can be used for various cell analysis and in vitro diagnosis, including cancer cells and stem cells, and can replace an optical microscope, and has excellent portability and price competitiveness. In particular, Sol Co., Ltd. is a powerful startup that has succeeded in international standardization (IEC 60747-18, etc.) of ‘characteristic evaluation methods for semiconductor biosensors and packages’ through the National Agency for Technology and Standards.
The agreement ceremony was held on the 7th (local time) in front of the CES 2023 Innovation Award-winning company pavilion in Las Vegas, USA, with Mayor Ki-jeong Kang and Jong-mook Lee, CEO of Sol Co., Ltd. in attendance. Sol Co., Ltd., headquartered in Seoul, has decided to build the world’s first semiconductor biosensor product research and development hub from 2023 to 2025, and to establish an AI corporate research center in Gwangju to create employment for about 20 people, including local talent. did.
To this end, Gwangju City decided to actively cooperate by providing administrative support and investment incentives in accordance with relevant regulations such as tax reductions, utilizing production-based technology infrastructure in the region, and securing excellent human resources. Gwangju City expects that this agreement will help build a big data platform to create and revitalize the Gwangju healthcare industry ecosystem by utilizing Sol’s technology and network, foster global talent, and strengthen the supply chain, which is an essential element of creating a special semiconductor zone. .
Jong-Mook Lee, CEO of Sol Co., Ltd. said, “With this agreement, Gwangju has become a partner and energy source for Sol Co., Ltd.’s great leap forward.” ·We will grow together with Gwangju by utilizing physical infrastructure to build a cloud and artificial intelligence (AI) platform that collects images of cells from around the world, including stem cells, immunity, and cancer.”
Gwangju Mayor Kang Ki-jeong said, “Sol Co., Ltd.’s decision to invest in the establishment of a research center based on innovative research results is an investment in Gwangju’s future.” He added, “Gwangju will take one step forward and grow bigger with biosensor research and development in the AI semiconductor field. “We will provide generous investment infrastructure support to Sol, which has become a stepping stone to becoming Korea’s Silicon Valley, the center of artificial intelligence in name and reality,” he promised.
Meanwhile, ‘CES’, the world’s largest IT exhibition, is an exhibition where you can understand the trends of the global home appliance industry at a glance. Hosted by the Consumer Technology Association (CTA), it is held every January in Las Vegas, USA. AVING News, which has covered CES for 1 consecutive years, has reported CES news around the world every year since 17, and has been selected as the ‘BEST OF CES’, which selects the best innovative products and technologies, and the ‘BEST OF’, which selects domestic innovative companies. ‘MADE IN KOREA’ was held. In addition, CES on-site issues were vividly conveyed through ‘AVING LIVE’.